Company Analysis

Innospec Inc. (IOSP)

Nasdaq: IOSP · Chemicals & Allied Products · Englewood, CO · filing with the SEC since 1998
Grade6.6
◀ Past 5.4● Present 7.8▶ Future 6.1

The grade of Innospec Inc.

Nine metrics read from its own filings, by tense
Headline grade
6.6/10
◀ Past5.430% of the headline
● Present7.840% of the headline
▶ Future6.130% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

All nine metrics read as filed from the record.

◀ Past

What did they actually do?

5.4/1030% of the headline grade · 3 of 3 filed

Surviving crises

as filed
4.7/10

Has it survived what it has been through?

3 warning events since 2017; the latest 2019-05-24.

weight 33% of this tense · 47th percentile among 16 sector filers · read for itself

From the record

Innospec Inc.'s filings since 2017 show 3 warning events: an auditor change (8-K item 4.01, 3 times, the latest 2019-05-24) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
7.1/10

What has it actually done, year after year?

+8.1% a year over 10 filed years; profitable in 10 of 10.

weight 45% of this tense · 71st percentile among 13 sector filers · read for its customers

From the record

Innospec Inc.'s 10 filed years say what it did: revenue went from $883 million in fiscal 2016 to $1.8 billion in fiscal 2025, up 8.1% a year; it rose in 5 of 9 years; the deepest fall was 21% from fiscal 2019 to fiscal 2020; net income was positive in 10 of 10 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span8.1%top 12% of its family
  • the share of years revenue rosebottom 42% of its family
  • the share of filed years with a profittop 12% of its family
  • the deepest fall from a revenue peak21.2%top 35% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

as filed
3.1/10

How has it treated the people who own it?

Share count steady. 27% of cash flow returned. Insiders: 18 sales, 2 purchases.

weight 22% of this tense · 31st percentile among 12 sector filers · read for its shareholders

From the record

Over the 3 fiscal years to 2025-12-31, Innospec Inc.'s diluted share count held steady, and dividends and buybacks returned about 27% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 18 sales and 2 purchases of their own stock on the open market in the year to 2026-11-12, buying about $53 thousand (their Form 4 filings).

What it rests on

  • the share count over the yearsbottom 41% of its family
  • cash returned against operating cash flowbottom 21% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

● Present

What are they doing right now?

7.8/1040% of the headline grade · 3 of 3 filed

Financial health

as filed
7.8/10

Is it financially healthy right now?

ROE 9%: 9¢ of profit per shareholder dollar. Leverage 28%: owes 28¢ per asset dollar.

weight 45% of this tense · 78th percentile among 15 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Innospec Inc. earned about 9 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 27 cents per dollar of everything the company owns. Leverage: it owed about 28 cents per dollar of assets, and net share issuance: its share count shrank 0.5% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetstop 37% of its family
  • return on equitytop 18% of its family
  • gross profit against assetstop 12% of its family
  • the share count against the year beforetop 23% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
7.4/10

How strong is its position in its industry?

top 26% of 15 in its family; net margin 6.6%.

weight 33% of this tense · 74th percentile among 15 sector filers · read for its customers

From the record

Innospec Inc.'s standing among 15 graded names in its industry family: revenue of $1.8 billion in fiscal 2025 ranks in the top 39% by size; a net margin of 6.6% ranks in the top 10%; revenue growth of -3.3% a year over the last 3 filed years ranks in the top 30% (its annual reports).

What it rests on

  • revenue against the family$1.78Btop 39% of its family
  • net margin6.6%top 10% of its family
  • three-year revenue growth-3.3%top 30% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

as filed
8.5/10

What are the people in charge doing?

top 15% of 12 in its family for leadership; chief executive since 2014.

weight 22% of this tense · 85th percentile among 12 sector filers · read for its shareholders

From the record

Innospec Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Williams, Patrick (PRESIDENT & CEO, as filed), filing under that title since 2014-02-18, 12.7 years (top 12% of its family); the 14 officers and directors filing in the last fifteen months have been on the record a median of 8 years (top 14%); 2 officer or director changes were reported on Form 8-K since 2023-11-13, against the 14 people in charge now (top 18%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

What it rests on

  • officer and director changes on Form 8-K, against the people in charge2 in three years among 14 peopletop 18% of its family
  • the median years the people in charge have filed8.0 yearstop 14% of its family
  • the chief executive's years on the record12.7 yearstop 12% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

▶ Future

What are they set up to do next?

6.1/1030% of the headline grade · 3 of 3 filed

Room to expand

as filed
6.6/10

How much room does it have to grow?

top 34% of 15 in its family for room to expand.

weight 45% of this tense · 66th percentile among 15 sector filers · read for itself

From the record

Innospec Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $293 million against no long-term debt tagged leaves 16% of its assets as net cash, top 22% of its family; cash from operations less capital spending is 7.8% of revenue (top 30%); a gross margin of 27.7% (top 42%); research spending of 2.9% of revenue (top 41%) (its annual report).

What it rests on

  • cash less debt against assets16.0%top 22% of its family
  • cash from operations less capital spending against revenue7.8%top 30% of its family
  • gross margin27.7%top 42% of its family
  • research spending against revenue2.9%top 41% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
5.7/10

What could actually drive growth from here?

top 43% of 13 in its family for growth drivers.

weight 33% of this tense · 57th percentile among 13 sector filers · read for its customers

From the record

Innospec Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -3.3% a year over the last three filed years against 8.1% over all 10, slowing (bottom 38% of its family); the newest year grew -3.7% (bottom 27%); research spending grew 9.6% a year (top 17%); capital spending grew 27% a year (top 19%) (its annual reports). Innospec Inc. reported 3 lines of business in fiscal 2025: Fuel Specialties at $702 million, Performance Chemicals at $681 million, Oilfield Services at $395 million. 2 of 3 grew in the latest filed year, and the largest line is 39% of revenue (its annual report).

What it rests on

  • three-year growth against the whole span-11.3 points a yearbottom 38% of its family
  • the newest year's revenue growth-3.7%bottom 27% of its family
  • three-year growth of research spending9.6%top 17% of its family
  • three-year growth of capital spending27.0%top 19% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
5.7/10

Did its newest year beat what its own record pointed to?

top 43% of 12 in its family for expectations against reality.

weight 22% of this tense · 57th percentile among 12 sector filers · read for its shareholders

From the record

Innospec Inc.'s newest year against its own record: revenue of $1.8 billion in fiscal 2025 came in 0.6% below the $1.8 billion its prior three years' pace pointed to (bottom 29% of its family); net income of $117 million against a prior three-year average of $103 million (top 21%); a net margin of 6.6% against 5.3% before (top 37%) (its annual reports).

What it rests on

  • revenue against the prior three years' pace-0.6%bottom 29% of its family
  • net income against the prior three years' average+14%top 21% of its family
  • net margin against its prior average+1.3 pointstop 37% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton IOSP · research, not advice